Downhill running affects the late but not the early phase of the rate of force development.


Journal

European journal of applied physiology
ISSN: 1439-6327
Titre abrégé: Eur J Appl Physiol
Pays: Germany
ID NLM: 100954790

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 06 08 2021
accepted: 11 05 2022
pubmed: 6 7 2022
medline: 19 8 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

This study aimed to evaluate the acute changes in the knee extensors maximum voluntary isometric contraction force (MVIC), rate of force development (RFD), and rate of EMG rise (RER) following a bout of downhill running. MVIC and RFD at 0-50, 50-100, 100-200, and 0-200 ms were determined in thirteen men (22 ± 2 yr) before and after 30 min of downhill running (speed: 10 km h MVIC, RFD Downhill running impairs the muscle capacity to produce maximum force and the overall ability to rapidly develop force. No change was observed for the early phase of the RFD and the absolute RER, suggesting no alterations in the neural mechanisms underlying RFD. RFD

Identifiants

pubmed: 35790580
doi: 10.1007/s00421-022-04990-8
pii: 10.1007/s00421-022-04990-8
pmc: PMC9381441
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2049-2059

Subventions

Organisme : Conseil régional de Bourgogne-Franche-Comté
ID : 2019-Y-09131
Organisme : Ministère de l'Enseignement Supérieur et de la Recherche
ID : #EA3920
Organisme : Tomsk Polytechnic University Development Program
ID : #TPU
Organisme : Università degli Studi di Milano
ID : #PSR2019_VERNILLO

Informations de copyright

© 2022. The Author(s).

Références

J Neurophysiol. 2020 Sep 1;124(3):763-773
pubmed: 32755359
Gait Posture. 2018 Jun;63:109-113
pubmed: 29729612
Sports Med. 2017 Apr;47(4):615-629
pubmed: 27501719
J Electromyogr Kinesiol. 2000 Oct;10(5):361-74
pubmed: 11018445
Scand J Med Sci Sports. 2017 Sep;27(9):945-955
pubmed: 27293016
Sports Med. 2006;36(11):977-99
pubmed: 17052133
Physiol Rep. 2017 Jan;5(2):
pubmed: 28108648
PLoS One. 2011 Feb 22;6(2):e17059
pubmed: 21364944
Physiol Rev. 2001 Oct;81(4):1725-89
pubmed: 11581501
Scand J Med Sci Sports. 2020 Sep;30(9):1632-1641
pubmed: 32396672
J Appl Physiol (1985). 2020 Apr 1;128(4):785-794
pubmed: 32163332
Scand J Med Sci Sports. 2016 Nov;26(11):1321-1333
pubmed: 26584478
PLoS One. 2013 Jun 26;8(6):e65596
pubmed: 23840345
Front Physiol. 2018 Nov 28;9:1627
pubmed: 30555337
J Physiol. 2019 May;597(9):2445-2456
pubmed: 30768687
Eur J Sport Sci. 2021 Jan;21(1):84-92
pubmed: 32090683
Med Sci Sports Exerc. 2018 Feb;50(2):334-343
pubmed: 28991037
J Exp Biol. 1985 Mar;115:125-36
pubmed: 4031760
J Appl Physiol (1985). 2004 Nov;97(5):1923-9
pubmed: 15258127
J Physiol. 2002 Aug 15;543(Pt 1):297-306
pubmed: 12181300
Sports Med. 2020 Dec;50(12):2083-2110
pubmed: 33037592
Gait Posture. 1998 Jan 1;7(1):77-95
pubmed: 10200378
J Sport Health Sci. 2022 May;11(3):319-329
pubmed: 34098176
Med Sci Sports Exerc. 2021 May 1;53(5):904-917
pubmed: 33148973
Int J Sports Med. 2020 May;41(5):275-284
pubmed: 32059243
J Appl Physiol (1985). 2008 Mar;104(3):739-46
pubmed: 18174392
Eur J Sport Sci. 2020 May;20(4):495-504
pubmed: 31311427
Physiol Rev. 2008 Jan;88(1):287-332
pubmed: 18195089
Neuromuscul Disord. 2012 Dec;22 Suppl 3:S181-6
pubmed: 23182636
J Appl Physiol (1985). 2002 Oct;93(4):1318-26
pubmed: 12235031
Front Hum Neurosci. 2021 Jul 09;15:701916
pubmed: 34305557
Appl Physiol Nutr Metab. 2019 Dec;44(12):1320-1328
pubmed: 31082324
Muscle Nerve. 2010 Dec;42(6):894-900
pubmed: 20928903
Med Sci Sports Exerc. 2014 Jun;46(6):1166-75
pubmed: 24195865
J Sci Med Sport. 2020 Nov;23(11):1100-1104
pubmed: 32416973
Exp Gerontol. 2019 Sep;124:110640
pubmed: 31252160
Exp Physiol. 2016 Dec 1;101(12):1552-1564
pubmed: 27652591
Eur J Sport Sci. 2018 Sep;18(8):1110-1118
pubmed: 29738677
Eur J Appl Physiol. 2016 Oct;116(10):1859-73
pubmed: 27456477
Eur J Appl Physiol. 2011 Nov;111(11):2723-33
pubmed: 21399960
J Sports Sci. 2021 Apr;39(7):815-825
pubmed: 33191845
Front Physiol. 2018 Oct 24;9:1503
pubmed: 30405448
Eur J Appl Physiol. 2016 Jun;116(6):1091-116
pubmed: 26941023
Int J Hist Sport. 2010;27(11):1877-91
pubmed: 20684085
J Sci Med Sport. 2011 May;14(3):270-4
pubmed: 21411367
Scand J Med Sci Sports. 2020 Sep;30(9):1642-1654
pubmed: 32485036
Sci Rep. 2017 Jul 18;7(1):5769
pubmed: 28720871
Eur J Appl Physiol. 2017 Sep;117(9):1845-1857
pubmed: 28687954
J Appl Physiol (1985). 2003 Sep;95(3):1090-6
pubmed: 12740314
Appl Physiol Nutr Metab. 2015 Jan;40(1):87-95
pubmed: 25494973

Auteurs

Giorgio Varesco (G)

Inter-University Laboratory of Human Movement Biology (EA 7424), UJM-Saint-Etienne, Université de Lyon, 42023, Saint-Etienne, France.

Giuseppe Coratella (G)

Department of Biomedical Sciences for Health, Università degli Studi di Milano, Building 2, via G. Colombo 71, 20133, Milan, Italy.

Vianney Rozand (V)

Inter-University Laboratory of Human Movement Biology (EA 7424), UJM-Saint-Etienne, Université de Lyon, 42023, Saint-Etienne, France.

Benjamin Cuinet (B)

Prognostic Factors and Regulatory Factors of Cardiac and Vascular Pathologies (EA3920), Exercise Performance Health Innovation (EPHI) Platform, University of Bourgogne Franche-Comté, 25000, Besançon, France.

Giovanni Lombardi (G)

Laboratory of Experimental Biochemistry and Molecular Biology, IRCCS Orthopedic Institute Galeazzi, 20161, Milan, Italy.
Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, 61-871, Poznań, Poland.

Laurent Mourot (L)

Prognostic Factors and Regulatory Factors of Cardiac and Vascular Pathologies (EA3920), Exercise Performance Health Innovation (EPHI) Platform, University of Bourgogne Franche-Comté, 25000, Besançon, France.
Division for Physical Education, Tomsk Polytechnic University, Tomsk Oblast, 634050, Russia.

Gianluca Vernillo (G)

Department of Biomedical Sciences for Health, Università degli Studi di Milano, Building 2, via G. Colombo 71, 20133, Milan, Italy. gianluca.vernillo@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH